AffyImmune Therapeutics, Inc. — Form D/A
AffyImmune Therapeutics, Inc. of NATICK, MA, a company, filed a Form D amendment with the SEC on 2018-11-28. The offering totals $14.6M, of which $7.9M was reported sold. Industry: Other Technology.
Offering
- Filed: 2018-11-28
- Form: D/A
- Accession: 0001752966-18-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $14.6M
- Amount sold: $7.9M
- Remaining: $6.8M
- Investors: 2
- Date of first sale: 2018-08-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-321277
Issuer
- Name: AffyImmune Therapeutics, Inc.
- CIK: 0001752966
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 12 MICHIGAN DR, NATICK, MA, 01760
- Phone: 6176991965
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Moonsoo Jin | Director | Natick, MA |
| Gang Song | Director | Natick, MA |
| Hong Fang Song | Director | Natick, MA |
| Moonsoo Jin | Executive Officer | Natick, MA |
| Gang Song | Executive Officer | Natick, MA |
Other filings by this issuer (1)
More